0001209191-23-016688.txt : 20230307
0001209191-23-016688.hdr.sgml : 20230307
20230307160411
ACCESSION NUMBER: 0001209191-23-016688
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230303
FILED AS OF DATE: 20230307
DATE AS OF CHANGE: 20230307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dethlefs Sven
CENTRAL INDEX KEY: 0001726010
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 23712531
MAIL ADDRESS:
STREET 1: 5 BASEL STREET, P.O. BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-03
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001726010
Dethlefs Sven
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
124 DVORA HANEVI'A ST.,
TEL AVIV
L3
6944020
ISRAEL
0
1
0
0
EVP, North America Commercial
Ordinary Shares
2023-03-04
4
M
0
13931
A
179312
D
Ordinary Shares
2023-03-04
4
M
0
38538
A
217850
D
Ordinary Shares
2023-03-05
4
M
0
24952
A
242802
D
Restricted Share Units
2023-03-03
4
A
0
99601
0.00
A
Ordinary Shares
99601
99601
D
Restricted Share Units
2023-03-04
4
M
0
13931
0.00
D
Ordinary Shares
13931
0
D
Restricted Share Units
2023-03-04
4
M
0
38538
0.00
D
Ordinary Shares
38538
115617
D
Restricted Share Units
2023-03-05
4
M
0
24952
0.00
D
Ordinary Shares
24952
49905
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources
and Compensation Committee, the cash value of one ordinary share.
Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027.
Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023.
Restricted share units were granted on March 4, 2022, with 33,538 vested on March 4, 2023, 33,538 vesting on each of March 4, 2024 and March 4, 2025, and 38,541 vesting on March 4, 2026.
Restricted share units were granted on March 5, 2021, with 24,952 vested on each of March 5, 2022, March 5, 2023 and March 5, 2024, and 24,953 vesting on March 5, 2025.
/s/ Dov Bergwerk as attorney-in-fact for Sven Dethlefs
2023-03-07